EUVIMEDEUVIMED entdecken
Crossref

Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities

Raja Reddy Kallem iD, Michael G Bartlett iD, Nuggehally R Srinivas

Biomedical Chromatography · 2026-12 · 40 (12)

DOI: 10.1002/bmc.70643 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 19.10.2026. Verfasst von Raja Reddy Kallem und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Pharmacometrics, Lundbeck Pharmaceuticals LLC, Deerfield, Illinois, USA. Hauptthemen laut MEDLINE: Liquid Chromatography-Mass Spectrometry, Tandem Mass Spectrometry. Die Arbeit nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Specificity assessment is essential in bioanalytical method development to ensure accurate analyte quantification in the presence of endogenous matrix components and potential exogenous interferences. Regulatory expectations have evolved over time, culminating in the harmonized ICH M10 guideline, which establishes a globally aligned framework for bioanalytical method validation. Although LC–MS/MS provides high analytical specificity, challenges remain, particularly from isobaric interferences and increasingly complex multi‐analyte assays. A common practical issue is trace contamination of authentic reference standards, such as parent drug in metabolite standards or vice versa, which can generate unacceptable cross‐signal contributions and compromise specificity assessments. When such impurities preclude conventional specificity testing, this perspective discusses scientifically justified approaches, including predetermined baseline corrections to account for contaminated standards. It also highlights incurred sample reanalysis (ISR) as a more meaningful assessment of assay specificity under these constrained conditions because it reflects the true in vivo composition of parent drug and metabolites. The application of ISR has emerged as a robust, regulatory‐endorsed tool for confirming assay reliability over time and, as such, could also serve as an alternative for some of the issues discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liquid Chromatography-Mass SpectrometryTandem Mass SpectrometryAnimalsHumansPharmaceutical PreparationsReference StandardsReproducibility of ResultsSensitivity and Specificity

Stichwörter der Autor:innen

ISRanalytical challengesbioanalysiscontaminantsspecificity

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • Department of Clinical Pharmacology and Pharmacometrics, Lundbeck Pharmaceuticals LLC, Deerfield, Illinois, USA.
  • Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, USA.

ORCID-Profile: Raja Reddy Kallem, Michael G Bartlett

Zitieren

APA

Kallem, R. R., Bartlett, M. G., & Srinivas, N. R. (2026). Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70643

Vancouver

Kallem RR, Bartlett MG, Srinivas NR. Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70643

BibTeX
@article{Kallem2026,
  author = {Kallem, Raja Reddy and Bartlett, Michael G and Srinivas, Nuggehally R},
  title = {Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {12},
  doi = {10.1002/bmc.70643}
}
Kostenlos starten →